All News
Filter News
Found 73,972 articles
-
Relation Therapeutics Teams up With Mila in Coalition to Identify COVID-19 Therapeutic Candidates
9/1/2020
Relation Therapeutics, a drug development company driven by data science and machine learning, announces Project RE, which will apply Relation Therapeutics’ and its partners’ technology to the identification of repurposed drug combinations as potential therapeutic candidates for COVID-19.
-
Envirotainer Opens New Station in Beijing, China
9/1/2020
Envirotainer, the global market leader in secure cold chain solutions for air transport of pharmaceuticals, announced that they are expanding their network of stations by adding Beijing, China, to the growing list of e-technology network stations.
-
First Patient Dosed in AstraZeneca’s Phase III COVID-19 Vaccine Trial at Headlands’ JEM Research Institute Site in Florida
9/1/2020
Headlands Research is pleased to announce that on Friday, Aug. 28, its JEM Research Institute clinical trial site in Lake Worth, Florida, successfully dosed the first North American patient in AstraZeneca’s Phase III COVID-19 vaccine trial.
-
Applied UV Announces Exercise of Over-Allotment Option
9/1/2020
Applied UV, Inc. announced in connection with its previously announced initial public offering of its common stock, the exercise by Network 1 Financial Securities, Inc., the managing underwriter of its overallotment option to purchase an additional 150,000 shares of common stock at a price of $5.00 per share less the underwriting discount.
-
Nationwide Kidney Risk Campaign Relaunches by National Kidney Foundation, U.S. Department of Health and Human Services, and American Society of Nephrology
9/1/2020
The National Kidney Foundation is joining forces with the U.S. Department of Health and Human Services, the American Society of Nephrology, and actor, activist and entrepreneur Wilmer Valderrama to reach the 1 in 3 American adults at risk for kidney disease.
-
Turning Point Therapeutics to Participate in Upcoming Investor Conferences - Sep 01, 2020
9/1/2020
Turning Point Therapeutics, Inc., a precision oncology company developing next-generation therapies that target genetic drivers of cancer, announced that President and CEO Athena Countouriotis, M.D., will participate in question and answer sessions at the Wells Fargo Virtual Healthcare Conference on Sept. 9 and the Citi 15th Annual BioPharma Virtual Conference on Sept. 10.
-
Starlight Children's Foundation Launches Stream For Starlight to Benefit Seriously Ill Children
9/1/2020
Starlight Children's Foundation, the organization dedicated to delivering happiness to seriously ill children and their families, announced the launch of its second annual Stream For Starlight.
-
CRH Medical Corporation Announces Completion of Majority Acquisition of Coastal Carolina Sedation Associates, LLC
9/1/2020
CRH Medical Corporation, announces that it completed an accretive transaction whereby the Company has acquired a 51% interest in Coastal Carolina Sedation Associates, LLC, a gastroenterology anesthesia practice located in Wilmington, North Carolina.
-
FibroGen to Present at Upcoming Investor Conferences
9/1/2020
FibroGen, Inc. (NASDAQ: FGEN) today announced that Enrique Conterno, Chief Executive Officer, will participate in fireside chats at the following virtual healthcare conferences: Citigroup 15th Annual BioPharma Conference on September 9, 2020 at 2:25 PM Eastern Time Morgan Stanley 18 th Annual Global Healthcare Conference on September 16, 2020 at 3:30 PM Eastern Time A live audio webcast will be available on the “Events & Presentation
-
Intabio Joins 17th Symposium on Mass Spectrometry with Podium Presentation from Merck Highlighting iCIEF-MS Applications for Forced Degradation Studies
9/1/2020
Intabio, Inc., a developer of analytical solutions that provides profound efficiency gains across all stages of biopharmaceutical development and manufacturing, today released details of several upcoming scientific presentations that highlight the power of Intabio's Blaze system. The presentations all are associated with the 17
-
Atara Biotherapeutics to Present 12-Month Data from All Four Cohorts in the Phase 1a Study of ATA188 in Progressive Multiple Sclerosis at MSVirtual2020
9/1/2020
Various Atara Posters Being Presented at ACTRIMS-ECTRIMS Further Elucidate the Role of EBV in MS Company to Host Live Conference Call and Webcast to Review MS Data Presentation on Friday, September 11, 2020 at 8:30 a.m. ET/5:30 p.m. CEST SOUTH SAN FRANCISCO, Calif.--( BUSINESS WIRE )-- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop treatments for pa
-
Soft Tissue Allografts Market: Speedy Recovery and Painless Treatment to Favor Growth
9/1/2020
Transparency Market Research has published a new report on the Soft tissue allografts market for the forecast period of 2019–2027.
-
Ophthalmic Steroids Drugs Market: Increase in the prevalence of intra ocular eye disorders is expected to boost the market
9/1/2020
Ophthalmic steroids are medicines that mainly contain corticosteroids. Corticosteroids are a class of steroid hormones that are produced in the adrenal gland of the body.
-
Direct-to-Consumer Laboratory Testing Market: Genetic Testing Segment to Gain Market Share
9/1/2020
According to the Food and Drug Administration (FDA), direct-to-consumer laboratory tests are diagnostic tests marketed directly to consumers without the involvement of a health care provider
-
3D Printed Implants Market: Growing Biomedical Applications of 3D Technology is Expected to Boost the Market
9/1/2020
The global 3D printed implants market is an important part of the growing larger trend, the 3D printing in medical applications.
-
Veterinary Ventilators Market: High prevalence of respiratory disease among veterinary animals to drive the market
9/1/2020
Veterinary ventilators are used in a wide variety of surgical conditions. Veterinary ventilation provides respiratory support for animals that are unable to maintain ventilation or oxygenation on their own.
-
Veterinary Catheters Market: Rising prevalence of chronic kidney diseases and cardiovascular diseases in animals
9/1/2020
Veterinary catheters are the tubes used to deliver medications, fluids, and gases to the body or to drain waste fluids such as urine from the body of the animals.
-
Synthetic Cannabinoids Market: Rise in Awareness about the Advantages of Synthetic Cannabis in the Treatment of Pain is Expected to Drive the Market
9/1/2020
Synthetic cannabinoids are human-made mind-altering chemicals found in the marijuana plant that provides medical benefits.
-
Vir Biotechnology and GlaxoSmithKline dosed the first patient last week in a Phase II/III clinical trial of VIR-7831, a fully human monoclonal antibody against COVID-19.
-
On Sunday, U.S. Food and Drug Administration Commissioner Stephen Hahn told the Financial Times that he would potentially fast-track a COVID-19 vaccine before clinical trials are done if it was “appropriate.”